EUVIMEDEUVIMED entdecken
Crossref

Scale‐Up Preparation of Manganese‐Iron Prussian Blue Nanozymes as Potent Oral Nanomedicines for Acute Ulcerative Colitis

Chengyun Hu, Xue Yuan, Ronghua Zhao, Biao Hong, Chuang Chen, Qingjun Zhu, Yanmin Zheng, Jinming Hu, Yue Yuan, Zhengyan Wu, Jia Zhang iD, Chaoliang Tang

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202400083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Chengyun Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Intelligent Machines, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China. Hauptthemen laut MEDLINE: Ferrocyanides, Colitis, Ulcerative, Iron, Manganese. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, Scientific Research Plan Project of Anhui Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prussian blue (PB) nanozymes are demonstrated as effective therapeutics for ulcerative colitis (UC), yet an unmet practical challenge remains in the scalable production of these nanozymes and uncertainty over their efficacy. With a novel approach, a series of porous manganese‐iron PB (MnPB) colloids, which are shown to be efficient scavengers for reactive oxygen species (ROS) including hydroxyl radical, superoxide anion, and hydrogen peroxide, are prepared. In vitro cellular experiments confirm the capability of the nanozyme to protect cells from ROS attack. In vivo, the administration of MnPB nanozyme through gavage at a dosage of 10 mg kg −1 per day for three doses in total potently ameliorates the pathological symptoms of acute UC in a murine model, resulting in mitigated inflammatory responses and improved viability rate. Significantly, the nanozyme produced at a large scale can be achieved at an unprecedented yield weighting ≈11 g per batch of reaction, demonstrating comparable anti‐ROS activities and treatment efficacy to its small‐scale counterpart. This work represents the first demonstration of the scale‐up preparation of PB analog nanozymes for UC without compromising treatment efficacy, laying the foundation for further testing of these nanozymes on larger animals and promising clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerrocyanidesColitis, UlcerativeIronManganeseAnimalsMiceNanomedicineReactive Oxygen SpeciesHumansAdministration, OralMale

Stichwörter der Autor:innen

Prussian bluemanganesenanozymesscale‐up preparationulcerative colitis

Substanzen

Ferrocyanidesferric ferrocyanideIronManganeseReactive Oxygen Species

Autor:innen und Institutionen

  • Institute of Intelligent Machines, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • Department of Anesthesiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
  • Department of Chemistry, University of Science and Technology of China, Hefei, 230026, China.
  • College & Hospital of Stomatology, Anhui Provincial Key Laboratory of Oral Diseases Research, Anhui Medical University, Hefei, 230032, China.
  • Anhui Provincial Key Laboratory of High Magnetic Resonance Image, High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • CAS Key Laboratory of Soft Matter Chemistry, Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei, 230026, China.

ORCID-Profile: Jia Zhang

Förderung

  • Natural Science Foundation of Anhui Province
  • Scientific Research Plan Project of Anhui Province
  • National Natural Science Foundation of China
  • Collaborative Innovation Program of Hefei Science Center, CAS
  • Science and Technology Major Project of Anhui Province

Zitieren

APA

Hu, C., Yuan, X., Zhao, R., Hong, B., Chen, C., Zhu, Q., Zheng, Y., Hu, J., Yuan, Y., Wu, Z., Zhang, J., & Tang, C. (2024). Scale‐Up Preparation of Manganese‐Iron Prussian Blue Nanozymes as Potent Oral Nanomedicines for Acute Ulcerative Colitis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202400083

Vancouver

Hu C, Yuan X, Zhao R, Hong B, Chen C, Zhu Q, et al. Scale‐Up Preparation of Manganese‐Iron Prussian Blue Nanozymes as Potent Oral Nanomedicines for Acute Ulcerative Colitis. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202400083

BibTeX
@article{Hu2024,
  author = {Hu, Chengyun and Yuan, Xue and Zhao, Ronghua and Hong, Biao and Chen, Chuang and Zhu, Qingjun and Zheng, Yanmin and Hu, Jinming and Yuan, Yue and Wu, Zhengyan and Zhang, Jia and Tang, Chaoliang},
  title = {Scale‐Up Preparation of Manganese‐Iron Prussian Blue Nanozymes as Potent Oral Nanomedicines for Acute Ulcerative Colitis},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202400083}
}
Kostenlos starten →